Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Stratified Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With Sickle Cell Disease With no Available Sibling Donor

NCT04201210 is registered in ClinicalTrials.gov with University of Regensburg as lead sponsor.

NCT NCT04201210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04201210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Stratified Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With Sickle Cell Disease With no Available Sibling Donor
Lead sponsor
University of Regensburg
Phase
Phase 2
Overall status
Recruiting
Start date
June 30, 2021
Completion date
March 31, 2030
Enrollment
212 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hbs disease, hemoglobin s disease, sickle cell anemia, sickle cell disease, sickle cell disorders, sickling disorder due to hemoglobin s